Company intelligence / Profile preview

Brighton Pharmaceuticals

Toms River, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Brighton Pharmaceuticals was a privately held specialty pharmaceutical company based in New Jersey that focused on the development and registration of generic prescription drugs. The company specialized in creating a pipeline of Abbreviated New Drug Applications (ANDAs) targeting therapeutic areas such as dermatology, women's health, and pain management. In 2008, Brighton Pharmaceuticals was acquired by Perrigo Company for approximately $20 million. This acquisition allowed Perrigo to significantly expand its generic Rx product portfolio and leverage Brighton's development expertise to strengthen its position in the US generic pharmaceutical market.

Therapeutic areas: NeurologyWomen's HealthDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Brighton Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brighton Pharmaceuticals.

Explore the full profile